Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
7.61
0.23 (3.12%)
At close: Aug 18, 2025, 10:46 AM
Contineum Therapeutics Class A Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -16.04M | -15.99M | -14.56M | -10.27M | -9.01M | -8.42M | -7.77M | -6.25M | 41.56M | -4.82M | -7.51M |
Depreciation & Amortization | 79K | 78K | 75K | 62K | 60K | 61K | 37K | 43K | 42K | 73K | 81K |
Stock-Based Compensation | 2.42M | 2.57M | 2.25M | 2.29M | 620K | 768K | 759K | 477K | 489K | 494K | 491K |
Other Working Capital | n/a | -2.92M | 2.57M | 1.66M | -379K | 345K | -2.17M | 463K | 1.97M | -1.3M | 396K |
Other Non-Cash Items | -2.12M | 13K | -913K | -573K | 209K | 158K | 263K | -765K | -2.2M | 385K | 2.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -1.08M | 2.95M | 2.32M | -209K | 275K | -2.79M | 1.12M | 1.66M | -1.01M | 419K |
Operating Cash Flow | -15.66M | -14.41M | -10.2M | -6.17M | -8.5M | -8.12M | -10.7M | -5.38M | 40.67M | -5.24M | -4.08M |
Capital Expenditures | -44K | -47K | -166K | -82K | -119K | -147K | -309K | -22K | -31K | -52K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -25.44M | -33.69M | -54.35M | -72.41M | -69.01M | -30.64M | -22M | -52.08M | -58.58M | -9.22M | -12.96M |
Sales Maturities Of Investments | 39.37M | 48.65M | 45.13M | 42.28M | 30.23M | 39.52M | 31.34M | 12.6M | 14.15M | 18.62M | 17.88M |
Other Investing Acitivies | n/a | n/a | n/a | 20K | n/a | 8.88M | 9.34M | n/a | n/a | 9.41M | 4.92M |
Investing Cash Flow | 13.88M | 14.91M | -9.39M | -30.18M | -38.9M | 8.73M | 9.03M | -39.5M | -44.46M | 9.36M | 4.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.13M | -625K | -625K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 91K | 24K | 642K | 13K | 108.36M | -18K | -322K | 111K | 49.91M | 8K | n/a |
Financial Cash Flow | 91K | 24K | 642K | 13K | 108.36M | 122K | -321K | 10.32M | 46.79M | -617K | -625K |
Net Cash Flow | -1.69M | 527K | -18.95M | -36.34M | 60.97M | 738K | -2M | -34.55M | 43.01M | 3.49M | 215K |
Free Cash Flow | -15.71M | -14.46M | -10.37M | -6.25M | -8.48M | -8.26M | -11.01M | -5.4M | 40.64M | -5.3M | -4.08M |